Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

We report on a currently 76-year-old female patient with relapsed/refractory (RR) multiple myeloma (MM) treated at our institution. This patient had received six lines of therapy including tandem autologous stem cell transplant, proteasome inhibitor, immunomodulatory drugs and CD38 antibody MOR202....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Immunopathol Pharmacol
Main Authors: Steinhardt, Maximilian Johannes, Zhou, Xiang, Krummenast, Franziska, Meckel, Katharina, Nickel, Katharina, Böckle, David, Messerschmidt, Janin, Knorz, Sebastian, Dierks, Alexander, Heidemeier, Anke, Lapa, Constantin, Einsele, Hermann, Rasche, Leo, Kortüm, Klaus Martin
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768838/
https://ncbi.nlm.nih.gov/pubmed/33353443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2058738420980258
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker